Related Experiment Video
Updated: May 29, 2025

Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture
Published on: February 11, 2019
LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Eunae You1,2, Bidish K Patel1, Alexandra S Rojas1
1Mass General Cancer Center, Harvard Medical School, Charlestown, Massachusetts.
Significance:
This study uncovers PDAC-specific mechanisms that dampen immune responses to viral-repeat RNA via long interspersed nuclear element 1 ORF1p. Suppression of ORF1p activates antiviral responses, reducing tumor growth and epithelial-mesenchymal transition. High ORF1p expression correlates with poor prognosis, highlighting its potential as a therapeutic target for PDAC.
Insights
Pancreatic ductal adenocarcinoma (PDAC) uses ORF1p protein to suppress antiviral immunity. Inhibiting ORF1p activates immune responses, slows tumor growth, and may offer a new therapeutic strategy for PDAC.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) often evades immune surveillance.
- Viral-repeat RNA elements can trigger immune responses within tumors.
- Long interspersed nuclear element 1 (LINE-1) open reading frame 1 protein (ORF1p) is implicated in cancer progression.
Purpose of the Study:
- To investigate the role of LINE-1 ORF1p in suppressing antiviral immune responses in PDAC.
- To determine if targeting ORF1p can modulate anti-tumor immunity and PDAC progression.
Main Methods:
- Analysis of ORF1p expression in PDAC tissues.
- In vitro and in vivo experiments to assess the impact of ORF1p suppression on immune cell activity.
- Evaluation of tumor growth and epithelial-mesenchymal transition (EMT) markers following ORF1p inhibition.
Main Results:
- PDAC utilizes ORF1p to specifically dampen immune responses against viral-repeat RNA.
- Suppression of ORF1p expression reactivates anti-viral immune signaling pathways.
- Reduced ORF1p levels led to decreased tumor growth and inhibited EMT.
- High ORF1p expression is correlated with poorer patient prognosis.
Conclusions:
- LINE-1 ORF1p is a key mechanism for immune evasion in PDAC.
- Targeting ORF1p represents a promising therapeutic strategy to enhance anti-tumor immunity in PDAC.
- Further research into ORF1p inhibitors could lead to novel PDAC treatments.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Abnormal Proliferation
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

